Exosome therapy is a non-surgical regenerative treatment for hair loss that delivers concentrated bioactive molecules — growth factors, cytokines, and RNA — directly into the scalp to stimulate dormant follicles, extend the active growth phase, and reduce the inflammation associated with androgenetic alopecia. At Hair of Istanbul, exosome therapy is available as a standalone treatment and as a complement to hair transplant surgery, administered by Dr. Hayriye Dilber under full clinical supervision.
Exosomes are nano-sized extracellular vesicles — measuring 30 to 150 nanometres — naturally secreted by stem cells as messengers between cells. They carry proteins, lipids, messenger RNA, and microRNA that regulate cellular behaviour, tissue repair, and regeneration. When exosomes derived from adipose-derived stem cells (ADSCs) or mesenchymal stem cells (MSCs) are injected into the scalp, they deliver thousands of growth signals simultaneously to hair follicle cells — stimulating dermal papilla activity, activating follicle stem cells, promoting new blood vessel formation, and reducing the chronic low-grade inflammation that drives follicle miniaturisation in androgenetic alopecia.
Multiple prospective clinical studies published between 2023 and 2025 — including Wan et al. (2023, n=72), Lee et al. (2024, n=58), and Park et al. (2024, n=39) — demonstrate significant improvements in hair density and shaft thickness at six months in AGA patients treated with ADSC-derived exosomes, with a consistently favourable safety profile and no serious adverse events reported. Exosome therapy is not a surgical procedure, does not require recovery time, and can be performed in a single clinical session of 30 to 60 minutes.
Exosome therapy involves scalp microinjections only — no incisions, no anaesthesia, no recovery period. Most patients return to normal activity the same day. Redness or mild sensitivity at injection sites resolves within 24–48 hours.
Prospective clinical studies show improvements in hair density and shaft thickness at six months with ADSC-derived exosome injections. Safety profiles across all published clinical series are consistently favourable with mild, transient local effects only.
Exosome therapy enhances post-transplant graft survival and recovery when applied at the time of surgery or in the weeks following. It also addresses native hair miniaturisation in areas where surgery cannot provide coverage.
Exosomes deliver a far higher concentration of bioactive growth signals than PRP, which relies on the patient's own platelet count. Each exosome carries thousands of growth factors, cytokines, and genetic instructions simultaneously to target follicle cells.
Hair loss stage, scalp condition, and treatment goals are assessed. Dr. Hayriye Dilber reviews your medical history and confirms whether standalone exosome therapy or a combined protocol with hair transplant or PRP is most appropriate.
Trichoscopic evaluation of density and miniaturisation pattern. Medical history reviewed including cardiovascular assessment by Dr. Hayriye Dilber. Treatment zone mapping and session count confirmed.
Scalp cleansed and prepared. Topical numbing applied. ADSC-derived exosomes injected via microinjection across the treatment zones. Session duration: 30–60 minutes. Normal activity resumed the same day.
Follow-up sessions spaced 4–6 weeks apart build on the initial biological response. Each session reinforces follicle stimulation, extends the anagen growth phase, and addresses progressive miniaturisation.
Reduced hair shedding and improved scalp condition are typically the first changes noticed — from weeks 4–8. Visible improvements in density and hair shaft thickness begin from month 2–3.
Optimal hair density and quality results are visible at 6 months following the full protocol. A maintenance session every 12 months sustains the biological response and prevents the progressive follicle miniaturisation from resuming.
Resume normal activities immediately. Avoid washing the scalp for 24 hours post-injection. Mild redness or sensitivity at injection sites is normal and resolves within 24–48 hours.
Resume normal hair washing with gentle, sulphate-free shampoo. Avoid direct sunlight, saunas, steam rooms, and swimming pools for the first week post-session.
Some patients notice a reduction in shedding within the first few weeks. Avoid heat styling or harsh chemical treatments during the active treatment period to support the follicle response.
Sessions are spaced 4–6 weeks apart. Maintain scalp hygiene as normal. Avoid topical products containing high concentrations of alcohol or harsh preservatives on the treatment area between sessions.
Visible improvements in density and hair shaft thickness begin. Hair quality — thickness, strength, and growth rate — typically improves before density changes become fully apparent.
Optimal results visible at 6 months following the full protocol. Annual maintenance sessions are recommended to sustain results and prevent the progressive miniaturisation associated with androgenetic alopecia from resuming.
Exosome therapy at Hair of Istanbul is appropriate for patients with early to moderate androgenetic alopecia, those seeking to complement or enhance a hair transplant result, and patients who prefer a non-surgical approach to hair restoration. It is not a replacement for surgical hair transplant in patients with advanced hair loss and insufficient native coverage — and Hair of Istanbul will always advise honestly on the most appropriate treatment for each patient’s specific situation.
Patients with Norwood I–IV (men) or Ludwig I–II (women) presenting with active miniaturisation are the strongest candidates. Exosome therapy is most effective when follicles are still present and responsive — not when they have been permanently lost.
Applied at the time of surgery or in the weeks following, exosome therapy supports graft survival, accelerates healing, and addresses miniaturisation in native hair areas surrounding the transplant zone — complementing the surgical result.
Patients who wish to delay or avoid surgery — or who are not yet surgical candidates due to hair loss being unstable — can use exosome therapy to slow progressive thinning and improve existing hair quality while the situation stabilises.
Exosome therapy has shown benefit in telogen effluvium and stress-related diffuse hair shedding by supporting follicle cycling recovery and reducing scalp inflammation. Assessment confirms whether the loss pattern is suitable for this approach.
Exosome therapy is a non-surgical regenerative treatment that delivers nano-sized extracellular vesicles — derived from adipose or mesenchymal stem cells — into the scalp via microinjection. Each exosome carries thousands of growth factors, cytokines, and RNA molecules that stimulate hair follicle activity, extend the active growth phase, promote scalp blood flow, and reduce the follicle inflammation that drives androgenetic alopecia. It is not a surgical procedure and requires no recovery time.
Exosome therapy and PRP operate through related but distinct mechanisms. PRP uses growth factors from the patient’s own platelets — the concentration varies by individual and processing method. Exosomes provide a standardised, concentrated payload of bioactive molecules significantly larger than what PRP can deliver. Published clinical comparisons suggest exosome therapy produces superior or comparable outcomes to PRP for hair density improvement, with a consistent safety profile. Both treatments can be used together where clinically indicated.
At Hair of Istanbul, a full exosome therapy protocol consists of 2–4 sessions, spaced 4–6 weeks apart. The number of sessions is determined during consultation based on hair loss stage, the extent of miniaturisation, and whether exosome therapy is being used as a standalone treatment or in combination with hair transplant or PRP. A maintenance session every 12 months is recommended to sustain results.
Most patients notice a reduction in daily hair shedding within the first 4–8 weeks. Visible improvements in hair density and shaft thickness typically become apparent from month 2–3. Optimal results are seen at 6 months following the full treatment protocol, consistent with published prospective clinical studies in AGA patients using ADSC-derived exosomes.
No. Exosome therapy stimulates existing follicles — it cannot create new ones or restore hair in areas where follicles have been permanently lost. For patients with advanced androgenetic alopecia where significant coverage is required, hair transplant surgery remains the definitive treatment. Exosome therapy is most valuable as a complement to transplant surgery, as a treatment to slow progressive miniaturisation, or for patients with early to moderate hair loss not yet requiring surgery.
The published clinical safety profile of ADSC-derived exosome therapy for hair loss is consistently favourable. Multiple prospective clinical series report only mild, transient local reactions — redness or sensitivity at injection sites — with no serious adverse events. At Hair of Istanbul, all exosome treatments are administered under full medical supervision by Dr. Hayriye Dilber, with pre-treatment assessment to confirm suitability.
Yes — and this is one of the most clinically valuable applications. Exosome therapy applied at the time of transplant surgery or in the weeks following has been shown to support graft survival, accelerate healing, and reduce post-operative inflammation. It also addresses native hair miniaturisation in the surrounding areas that surgery cannot cover — complementing and extending the transplant result. At Hair of Istanbul, combined protocols are assessed and planned individually.
Exosome therapy at Hair of Istanbul is administered by Dr. Hayriye Dilber, who manages pre-treatment cardiovascular and medical assessment and oversees the full treatment protocol. All exosome sessions take place within the clinical environment at Hair of Istanbul under physician supervision — not in a cosmetic or non-medical setting.
Get in touch for a free consultation. Our multilingual team is ready to answer your questions and guide you through the process.
Fill out the form and our team will contact you within 24 hours.